 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
| Mike van der Meer PhD
• Director Mike founded the original analytical facility (GBN Analytics) in South Africa in 1989. The company has evolved over the years and now operates as Trident Bioanalytics in Ireland. With a PhD in pharmacology and involvement in more than 500 clinical trials he acts as study director for all Phase 1 studies at Trident.
• R&D Director / Lab manager With more than 25 years experience in analytical pharmacology, having qualified at Farmovs in South Africa in 1979, Leslie has been involved in more than 500 Phase 1 clinical trials. His accumulated knowledge makes him eminently qualified as R&D Director at Trident.
|  |
|
 |
||
 Trident Bioanalytics Limited.® All rights reserved. |
||